Editas Medicine (EDIT) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$1000.0.
- Editas Medicine's Other Non Operating Income rose 8000.0% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 1552142.86%. This contributed to the annual value of -$3000.0 for FY2024, which is 9981.3% up from last year.
- Latest data reveals that Editas Medicine reported Other Non Operating Income of -$1000.0 as of Q3 2025, which was up 8000.0% from -$1.8 million recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Other Non Operating Income ranged from a high of $235000.0 in Q2 2022 and a low of -$1.8 million during Q2 2025
- Its 5-year average for Other Non Operating Income is -$208666.7, with a median of -$2000.0 in 2021.
- Per our database at Business Quant, Editas Medicine's Other Non Operating Income skyrocketed by 2360000.0% in 2022 and then crashed by 17570000.0% in 2025.
- Editas Medicine's Other Non Operating Income (Quarter) stood at -$1000.0 in 2021, then plummeted by 300.0% to -$4000.0 in 2022, then plummeted by 250.0% to -$14000.0 in 2023, then surged by 78.57% to -$3000.0 in 2024, then skyrocketed by 66.67% to -$1000.0 in 2025.
- Its Other Non Operating Income stands at -$1000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$425000.0 for Q1 2025.